Full virus vaccine at least a year away says EU agency

Image
AFP The Hague
Last Updated : Mar 31 2020 | 11:42 PM IST

It will be at least another year before a vaccine against the new coronavirus will be ready for approval and available in sufficient quantities, the EU medicines agency said Tuesday.

As the number of declared coronavirus cases worldwide passed 800,000 on Tuesday, according to an AFP tally, the race is on to develop a vaccine against COVID-19 which emerged from China late last year.

The European Medicines Agency said in a statement it "estimates that it might take at least one year before a vaccine against COVID-19 is ready for approval and available in sufficient quantities to enable widespread use".

This was based on current available information and past experience with vaccine development timeframes, the Amsterdam-based agency said.

It added that two vaccines have already entered a first phase of a clinical trials that was carried out on healthy volunteers.

But in general "timelines for the development of medicinal products are difficult to predict", the EMA said.

So far, no medicine has yet shown to be a treatment for the coronavirus, that has so far claimed some 40,000 lives.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 31 2020 | 11:42 PM IST

Next Story